KKM Bans Sale of ‘Hong Thai Inhaler’ After Bacterial Contamination Alert
KKM Bans Sale of ‘Hong Thai Inhaler’ After Bacterial Contamination Alert
KKM Issues Warning Against Hong Thai Inhaler
The Ministry of Health Malaysia (KKM) has issued a strict warning to the public not to purchase or use the popular herbal nasal inhaler from Thailand, Hong Thai Inhaler, after it was confirmed to contain harmful bacterial contamination.
The ministry stated that the product was recently withdrawn in Thailand following laboratory findings that detected dangerous bacteria in several batches.
Product Still Widely Available Online
KKM’s preliminary investigations found that Hong Thai Inhaler remains widely listed for sale by both local and international sellers on online marketplaces and e-commerce platforms.
“Immediate control measures have been implemented, including filtering product listings and blocking sales links associated with the product. Enforcement actions will continue against any sellers found distributing this unregistered item,” the ministry stated.
Not Registered With DCA and Banned in Malaysia
KKM confirmed that Hong Thai Inhaler is not registered with the Drug Control Authority (DCA) and therefore cannot be legally sold or distributed in Malaysia — whether through physical stores or online platforms.
The ministry emphasized that the product poses a serious public health risk due to bacterial contamination, including Clostridium spp., which can cause severe infections.
Over 335 Listings Identified and Removed
Through its Pharmaceutical Enforcement Division, KKM has identified more than 335 online listings of the product and has directed e-commerce platforms to take down the advertisements immediately in order to protect public safety.
The ministry reminded that selling or possessing unregistered medicines is an offence under Regulation 7(1)(a) of the Control of Drugs and Cosmetics Regulations 1984, punishable under Section 12 of the Sale of Drugs Act 1952.
Individuals found guilty can face fines up to RM25,000 or imprisonment of up to three years, while companies can be fined up to RM50,000.
Continuous Monitoring and Legal Enforcement
KKM reaffirmed its commitment to proactive monitoring of medical and health-related advertisements, especially on online platforms, to ensure full compliance with Malaysian laws.
The ministry enforces several key legislations, including the Sale of Drugs Act 1952, Poisons Act 1952, and the Medicines (Advertisement and Sale) Act 1956, to safeguard public health and prevent misleading or unsafe product promotions..
DISCLAIMER: NasiLemakDaily is not responsible for any comments written by readers. Please think carefully before posting. We are also unable to monitor every comment posted. All comments are your own responsibility.
Source : KKM
